EAM Investors LLC bought a new stake in shares of STRATA Skin Sciences Inc (NASDAQ:SSKN) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 234,539 shares of the medical device company’s stock, valued at approximately $830,000. EAM Investors LLC owned approximately 0.78% of STRATA Skin Sciences at the end of the most recent reporting period.
A number of other institutional investors have also made changes to their positions in the business. Nantahala Capital Management LLC bought a new stake in STRATA Skin Sciences during the 2nd quarter valued at $4,261,000. Menora Mivtachim Holdings LTD. acquired a new position in shares of STRATA Skin Sciences during the 2nd quarter valued at $1,138,000. Renaissance Technologies LLC increased its position in shares of STRATA Skin Sciences by 164.6% during the 2nd quarter. Renaissance Technologies LLC now owns 293,499 shares of the medical device company’s stock valued at $602,000 after purchasing an additional 182,579 shares during the period. Finally, Macquarie Group Ltd. increased its position in shares of STRATA Skin Sciences by 89.7% during the 2nd quarter. Macquarie Group Ltd. now owns 134,033 shares of the medical device company’s stock valued at $275,000 after purchasing an additional 63,393 shares during the period. 30.63% of the stock is currently owned by hedge funds and other institutional investors.
Shares of SSKN stock opened at $2.74 on Friday. STRATA Skin Sciences Inc has a 1 year low of $1.09 and a 1 year high of $3.88. The firm has a market cap of $78.15 million, a PE ratio of 1.39 and a beta of 0.82. The company has a debt-to-equity ratio of 0.22, a quick ratio of 4.03 and a current ratio of 4.54.
SSKN has been the topic of several research analyst reports. Zacks Investment Research cut STRATA Skin Sciences from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 1st. HC Wainwright set a $3.00 price target on STRATA Skin Sciences and gave the company a “buy” rating in a research report on Tuesday, August 14th. Finally, Dawson James initiated coverage on STRATA Skin Sciences in a research report on Tuesday, September 4th. They set a “buy” rating on the stock.
WARNING: This piece was first published by WKRB News and is owned by of WKRB News. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://www.wkrb13.com/2018/11/23/eam-investors-llc-takes-830000-position-in-strata-skin-sciences-inc-sskn.html.
STRATA Skin Sciences Company Profile
STRATA Skin Sciences, Inc, a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions.
Further Reading: Investing in Dividend Stocks
Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.